Cost-effectiveness of interventions to prevent disability in leprosy: A systematic review

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  van Veen, Natasja H J ^a   McNamee, Paul ^b   Richardus, Jan Hendrik ^a   Smith, W Cairns S ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DISABILITY; ECONOMIC EVALUATION; FOOT ULCER; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; LEPROSY; LIFE EXPECTANCY; NEURITIS; PROTECTIVE EQUIPMENT; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; SELF CARE; SHOE; STRATEGIC PLANNING; SURGICAL TECHNIQUE; SUSTAINABLE DEVELOPMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84873246964     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004548     Document Type: Review

References (34)

1. Britton WJ, Lockwood DN (2004) Leprosy. Lancet 363: 1209-1219.
2. Meima A, van Veen NH, Richardus JH (2008) Future prevalence of WHO grade 2 impairment in relation to incidence trends in leprosy: an exploration. Trop Med Int Health 13: 241-246.
3. Anonymous (2002) Towards a common language for functioning, disability and health - ICF. Geneva: World Health Organization. 22 p.
4. Rafferty J (2005) Curing the stigma of leprosy. Lepr Rev 76: 119-126.
5. Cross H, Choudhary R (2005) STEP: An intervention to address the issue of stigma related to leprosy in Southern Nepal. Lepr Rev 76: 316-324.
6. Scott J (2000) The psychosocial needs of leprosy patients. Lepr Rev 71: 486-491.
7. Anonymous (2002) Report of the International Leprosy Association Technical Forum. Paris, France. Indian J Lepr 74: S1-S93.
8. Anonymous (2006) Consensus statement on prevention of disability. Lepr Rev 77: 387-395.
9. Victora CG, Hanson K, Bryce J, Vaughan JP (2004) Achieving universal coverage with health interventions. Lancet 364: 1541-1548.
10. Van Veen NH, Nicholls PG, Smith WC, Richardus JH (2007) Corticosteroids for treating nerve damage in leprosy. Cochrane Database Syst Rev. CD005491.
11. Van Brakel WH, Anderson AM, Withington SG, Croft RP, Nicholls PG, et al. (2003) The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2). Lepr Rev 74: 300-310.
12. Richardus JH, Withington SG, Anderson AM, Croft RP, Nicholls PG, et al. (2003) Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3). Lepr Rev 74: 311-318.
13. Reinar LM, Forsetlund L, Bjorndal A, Lockwood D (2008) Interventions for skin changes caused by nerve damage in leprosy. Cochrane Database Syst Rev. pp CD004833.
14. Salazar J, Serrano G, Leon-Quintero G (2001) Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian J Lepr 73: 103-110.
15. Bansal NK, Mukul (1993) Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. Int J Dermatol 32: 210-213.
16. Bhatia A, Nanda S, Gupta U, Gupta S, Reddy B (2004) Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double-blind, comparative study. J Dermatol Treat 15: 321-327.
17. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL (2005) Methods for the economic evaluation of health care programmes. New York: Oxford University Press. 379 p.
18. Naik SS, Ganapati R (1998) Socioeconomics of a global leprosy eradication programme. Pharmacoeconomics 13: 677-86.
19. Max E, Shepard DS (1989) Productivity loss due to deformity from leprosy in India. Int J Lepr Other Mycobact Dis 57: 476-482.
20. Kingsley S, Tripathi AP, Ganapati R, Pillai ARK (1998) Low cost disability management in leprosy - an experiment in an urban slum. Int J Lepr. 72A.
21. Plag I (1995) Guidelines for cost analysis in leprosy control programmes. Amsterdam: Royal Tropical Institute. 30 p.
22. Seboka G, Alert PS (1996) Cost-effective footwear for leprosy control programmes: a study in rural Ethiopia. Lepr Rev 67: 208-216.
23. Ravi HN, George R, Eapen EP, Pulimood SA, Gnanamuthu C, et al. (2004) A comparison of economic aspects of hospitalization versus ambulatory care in the management of neuritis occurring in lepra reaction. Int J Lepr 72: 448-456.
24. Remme JHF, Feenstra P, Lever PR, Medici A, Morel C, et al. (2006) Tropical diseases targeted for elimination: Chagas disease, lymphatic filariasis, onchocerciasis, and leprosy. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, et al., eds. Disease control priorities in developing countries. New York: The World Bank and Oxford University Press. pp 433-449.
25. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, et al. (2006) Disease control priorities in developing countries. New York: The World Bank and Oxford University Press. 1352 p.
26. Musgrove P (2000) A critical review of 'A critical review'1: the methodology of the 1993 World Development Report, 'Investing in Health'. Health Policy Plan 15: 110-115.
27. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, eds (2006) Global burden of disease and risk factors. New York: The World Bank and Oxford University Press. 29 p.
28. Musgrove P, Fox-Rushby J (2006) Cost-effectiveness analysis for priority setting. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, et al., eds. Disease control priorities in developing countries. New York: The World Bank and Oxford University Press. pp 271-285.
29. Madhavan K, Vijayakumaran P, Ramachandran L, Manickam C, Rajmohan R, et al. (2007) Sustainable leprosy related disability care within integrated general health services: findings from Salem District, India. Lepr Rev 78: 353-361.
30. Li J, Mu H, Ke W, Bao X, Wang Y, et al. (2008) Government health workers as implementers of prevention of disability measures: an assessment of a prevention of disability project in selected counties of Guizhou Province, Peoples' Republic of China. Lepr Rev 79: 295-302.
31. Suma TK, Shenoy RK, Kumaraswami V (2002) Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis. Trop Med Int Health 7: 763-766.
32. Mpyet C, Dineen BP, Solomon AW (2005) Cataract surgical coverage and barriers to uptake of cataract surgery in leprosy villages of north eastern Nigeria. Br J Ophthalmol 89: 936-938.
33. SALSA Collaborative Study Group (2007) The development of a short questionnaire for screening of activity limitation and safety awareness (SALSA) in clients affected by leprosy or diabetes. Disabil Rehabil 29: 689-700.
34. van Brakel WH, Anderson AM, Mutatkar RK, Bakirtzief Z, Nicholls PG, et al. (2006) The Participation Scale: measuring a key concept in public health. Disabil Rehabil 28: 193-203.